Darifenacin Tablet, Extended Release
Product Images NDC 46708-224

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Darifenacin (NDC 46708-224). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Alembic Pharmaceuticals Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

30's Bottle Pack (Darifenacin 15mg)

30's Bottle Pack (Darifenacin 15mg)
Each tablet contains 17,858 mg of darifenacin hydrobromide, providing 15 mg of darifenacin. This is an Extended-Release medication that comes in a bottle of 30 tablets. It is recommended to store this medication at 25°C (77°F) with excursions permitted for 15 to 30°C (59-86°F) and to protect from light. This medication requires a prescription and should be kept out of the reach of children. NDC number is 46708-224-30.*
FDA Label Image

30's Bottle Pack (Darifenacin 75mg)

30's Bottle Pack (Darifenacin 75mg)
Each tablet contains 8.929 mg of darifenacin hydrobromide to provide 7.5mg darifenacin. The usual dosage is one tablet a day. It should be stored at 25°C (77°F), with excursions permitted to 15-30°C (59-86°F), protected from light. This drug should be kept out of the reach of children. The NDC for this medication is 46708-223-30. This is an extended-release tablet with 30 tablets in the package. The drug is manufactured by Alembic Pharmaceuticals Limited in Panelav Village, Panchmahal, Gujarat, India. The lot number and expiration date are not available.*
FDA Label Image

Figure 1 (Darifenacin Figure1)

Figure 1 (Darifenacin Figure1)
This is a chart showing Darifenacin plasma concentration (in ng/mL) at different times post-dose (in hours). The chart includes data for 7.5mg and 15mg doses of Darifenacin, and separates the results for extensive metabolizers (EMs) from poor metabolizers (PMs). The chart shows the mean, as well as the standard deviation (SD) for each set of data, but there are no units provided for the y-axis.*
FDA Label Image

Figure 2a (Darifenacin Figurea2)

FDA Label Image

Figure 2b (Darifenacin Figureb2)

FDA Label Image

Figure 2c (Darifenacin Figurec2)

FDA Label Image

Structure (Darifenacin Str)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.